Oberhammer Lukas, Mitterberger Michael Josef, Lusuardi Lukas, Kunit Thomas, Drerup Martin, Colleselli Daniela, Griessner Hubert, Hager Martina
Department of Urology and Andrology Uniklinikum Salzburg Salzburg Austria.
Department of Pathology Uniklinikum Salzburg Salzburg Austria.
Clin Case Rep. 2019 Oct 7;7(12):2321-2326. doi: 10.1002/ccr3.2466. eCollection 2019 Dec.
In renal tumors, suspicious for renal cell carcinoma, where there is any doubt and discrepancy between morphology and immune profile, we recommend performing further immunohistochemical staining for pan-cytokeratin, S100, NSE, and inhibin-alpha. Thus, follow-up overtreatment can be avoided in cases of benign kidney tumors.
在怀疑为肾细胞癌的肾肿瘤中,若形态学与免疫表型之间存在任何疑问和差异,我们建议进一步进行全细胞角蛋白、S100、神经元特异性烯醇化酶和抑制素α的免疫组化染色。因此,对于良性肾肿瘤病例,可以避免后续的过度治疗。